Participate in Our Study
Trial Purpose
This study will collect bone marrow (BM) aspirate samples from patients with relapsed refractory multiple myeloma (RRMM) prior to the start of a new treatment regimen for the purposes of prospectively measuring mass accumulation rate (MAR) as a biomarker of patient response to that regimen.
The primary study objective is to explore whether the MAR biomarker can predict patient response in RRMM patients. In order to enable this primary objective, two patient groups will be required. First, a small number of patients with recently diagnosed with multiple myeloma and never treated (Vanguard cohort) will be enrolled to help define drug concentrations used for testing. A second larger group of patients with RRMM will then be enrolled and serve as the primary study cohort. Data will be collected to estimate the biomarker’s predictive properties and to support improvement of the MAR biomarker through additional research and discovery based on the data collected during the study.

Trial Summary











Where to Participate
Title | Address | Description |
---|---|---|
Dana Farber Cancer Institute | 450 Brookline Ave, Boston, MA 02215, USA | |
Massachusetts General Hospital | 55 Fruit St, Boston, MA 02114, USA | |
Weill Medical College of Cornell University | 407 E 61st St, New York, NY 10065, USA | |
Icahn School of Medicine at Mount Sinai | 1 Gustave L. Levy Pl, New York, NY 10029, USA | |
Emory University Hospital | 1365c Clifton Rd, Atlanta, GA 30322, USA | |
City of Hope Comprehensive Cancer Center | 1500 E Duarte Rd, Duarte, CA 91010, USA |
Locations
Dana Farber Cancer Institute, Boston MA
450 Brookline Ave.
Boston, MA 02215
Status: Enrolling
CLICK HERE if you are interested in contacting someone to discuss participation in this study.
Massachusetts General Hospital, Boston MA
55 Fruit Street
Boston, MA 02114
Status: Enrolling
CLICK HERE if you are interested in contacting someone to discuss participation in this study.
Icahn School of Medicine At Mount Sinai, New York, NY
1 Gustave L. Levy Place
New York, NY 10029
Status: Enrolling
CLICK HERE if you are interested in contacting someone to discuss participation in this study.
Weill Cornell Medicine - New York Presbyterian, New York, NY
525 East 68th Street
New York, NY 10065
Status: Enrolling
CLICK HERE if you are interested in contacting someone to discuss participation in this study.
City of Hope Comprehensive Cancer Center, Duarte, CA
1500 E Duarte Road
Duarte, CA 91010
Status: Enrolling
CLICK HERE if you are interested in contacting someone to discuss participation in this study.
Emory University, Atlanta, GA
1365-C Clifton Road NE
Atlanta, GA 30322
Status: Enrolling
CLICK HERE if you are interested in contacting someone to discuss participation in this study.

